Fungal medicine, fuscoporia obliqua, as a traditional herbal medicine: Its bioactivities, in vivo testing and medicinal effects

Asian Biomedicine

Volumn 2, Issue 6, 2008, Pages 459-469

  Koyama, Tomiyasu ^a   Gu, Yeunhwa ^b   Taka, Akira ^c  

^a Suzuka University of Medical Science ^*  (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Sapporo Aoba Holistic Academy   (Japan)

Author keywords

Anti cancer; Antioxidant; Antisepsis; Antivirus; Beta glucan

Indexed keywords

ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BETA GLUCAN; ERGOSTEROL; FUSCOPORIA OBLIQUA EXTRACT; GLUCOSE; LANOSTEROL; LENTENULA EDODES EXTRACT; LIGNIN; LIPID; PLANT EXTRACT; TRAMETENOLIC ACID; TRITERPENE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CARDIOVASCULAR FUNCTION; CELL CYCLE REGULATION; CELL PROTECTION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ESSENTIAL HYPERTENSION; FUSCOPORIA OBLIQUA; GAP JUNCTION; GLUCOSE BLOOD LEVEL; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; IN VIVO STUDY; INFECTION; LENTENULA EDODES; LIPID BLOOD LEVEL; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAW EDEMA; RADIATION PROTECTION; REVIEW; SEPTIC SHOCK; SINGLE DRUG DOSE;

EID: 70349292907     PISSN: 19057415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Lindequist U, Niedermeyer THJ, Juelich W-D. The pharmacological potential of mushrooms. Evidence-based Complem Alternat Med. 2005;2:285-299.
2. Morikawa K, Takeda R, Yamazaki M, Mizuno D. Induction tumoricidal activity of polymorphonuclear leukocytes by a linear β-1,3-D-glucan and other 1. immuno-modulators in murine cells. Cancer Res .1985; 45:1496-1501. (Pubitemid 15079093)
3. Matsushita K, Kuramitsu Y, Ohiro Y, Hosokawa M. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastases of rat mammary adnocarcinoma. AntiCancer Drugs. 1998;9:343-350.
4. Solzhenitsy A. Cancer Ward. London:The Brodley Head. Cited from a Japanese edition (translated by Ogasawara T), Tokyo:Shinchou Co, 1969.
5. Sekiba F. An account of Ainu medicine. In: A collection of materials on the Ainu history. Private publication (in Japanese), 1895.
6. Watanabe O, Abe T, Kawakami M, Kakimoto M; Antioxidation by water-soluble lignin-like substance from a northern terrain basidiomycetes, Fuscoporia obliqua. Bull Hokkaido Food Processing Res Center. 2005;6:13-16.
7. Shyadehi AZ, Lamb DC, Kelly SL, Schunck WH, Wright JN, Corina D, Akhtar M. The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14 alpha-demethylase of Candida albicans(other names are lanosterol 14 alpha-demethylase, P45014DM, and Cyp51). J Biol Chem. 1996;271:12445-12450.
8. Nakata T, Yamada T, Taji S, Ohishi H, Wada S, Tokuda H, et al. Structure determination of inototsuoxide A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Tinonotus obliquus. Bioorg Med Chem. 2007;15:257-264.
9. Zheng WF, Liu T, Xiang XY, Gu Q. Sterol composition in field-grown and cultured mycelia of Inonotus obliquus. Yao Xue Xue Bao. 2007;42:750-756.
10. Pratsinis Z, Aligiannis N, Manoussakis M, Moutsatsou P. Antioxidants. J Cancer Res Clin Oncol. 2007;133:493-500.
11. Kim KB, Lotan R, Yue P, Sporn MB, Suh N, Gribble GW, et al. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12- dioxooleana-1, 0-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells. Mol Cancer Ther. 2002;3:177-184.
12. Cui Y, Kim DS, Park KC. Antioxidant effect of Inonotus obliquus. J Ethnopharmacology. 2005;96:79-85.
13. Lee SO, Kim MJ, Kim DG, Choi HJ. Antioxidative activities of temperature-stepwise water-extracts from Inonotus obliquus. J Korean Soc Food Sci Nutrition. 2005;34:139-147.
14. Sakurai K, Shinkai S. Molecular recognition of adenine, cytosine, and uracil in a single-stranded RNA by a natural polysaccharide: Schizophyllan. J Am Chem Soc. 2000;122:4520-4521.
15. Miyoshi K, Uezu K, Sakurai S. Polysaccharide-polynucleotide complexes. Part 32. Structural analyses of the curdian/poly (cytidylic acid) complex with semiempirical molecular orbital calculations. Biomacromolecules. 2005;6:1540-1546.
16. Vetvicka V, Thornton BP, Ross GD. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell compartment receptor type 3 b (CD11b/CD18 generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest. 1996; 98:50-61.
17. Hong F, Yan J, Bran JT, Ross GD. Mechanisms by which orally administered beta 1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol. 1996; 173:797-806.
18. Hong F, Hanson RD, Yan J, Ross GD. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruitiung tumoricidal granulocytes as killer cells. Cancer Res. 2003;63: 9024-9031.
19. Spierings EL, Fujii H, Sun B, Walshe T. A phase 1 study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. J Nutr Sci Vitaminol. 2007;53:536-539.
20. Ritz BW, Nogusa S, Ackerman EA, Gardner EM. Supplement with active hexose correlative compound increases the innate immune response of young mice to primary influenza infection. J Nutr. Nutrition Immunol. 2006;136:2868-2873.
21. Kupin VI, Dictionary for Herbal Medicine, Moskva Medical and Engineering University, 1990; p.187-189, p.255. Cited from Mizuno T. Chem Times. 1997;1:1-15.
22. Nakajima Y, Sato Y, Konishi T. Antioxidant small phenolic ingredients in Inonotus obliquus (person) Pilat (Cahaga). Chem Pharma Bull (Tokyo). 2007;55: 12222-12226.
23. Kim YO, Han SB, Lee HW, Ahn HJ, Yoon YD, Jung JK, et al. Immuno-stimulating effect of the endopolysaccharide produced by submerged culture of Inonotus obliquus. Life Sci. 2005;77:2438-2456.
24. Antimitotic activity of aqueous extracts of Inonotus obliquus. Burczyk J, Gawron A, Slotwinska M, Smietana B, Terminska K. Boll Chim Farm. 1996;135:306-309.
25. Youn MJ, Kim JK, Park SY, Kim Y, Kim SJ, Lee JS, et al. Chaga mushroom (Inonotus obliquus) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells. World J Gastro-Enterol. 2008;14:511-517.
26. Park JR, Park JS, Jo EH. Reversal of the TPA-induced inhibition of gap junctional intercellular communication by Chaga mushroom (Inonotus obliquus) extracts: effects on MAP kinases. Biofactors .2006;27:145-155.
27. Sung B, Pandey MK, Nakajima Y, Nishida H, Konishi T, Chaturvedi M, et al. Identification of a novel blocker of IkappaBalpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaB. Mol Cancer Ther. 2008;7:191-201.
28. Mori H, Otake T, Yamasaki K, Nishio M, Morimoto M, Ueba N. Anti-HIV-1 activity of the extract of Fuscoporia obliqua. Abstract Int Conf AIDS. 1994; 1PA0318.
29. Kim YO, Park HW, Kim JH, Lee JY, Moon SH, Shin CS. Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci. 2006;79:72-80.
30. Park YM, Won JH, Kim YH, Choi J, Park H, Lee K. In vivo and in vitro anti-inflammatory and antinociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol. 2005;101:120-128. (Pubitemid 41265611)
31. Koch J, Witt S, Lindequist U. The influence of selected basidiomycetes on the binding of lipopolysaccharide to its receptor. Int J Med Mushrooms. 2002;4:229-235. Cited from [1].
32. Miura T, Tsuchiya M, Itoh Y, Okamoto H, Noji M, Suzuki I. Anti-diabetic activity of Fuscoporia obliqua in KK-Ay mice. J Traditional Med. 2004;21:39-41.
33. Miura T, Kurata M, Takagi S, Ishibashi C. Effect of Fuscoporia obliqua with exercise on blood glucose and lipid in type 2 diabetic mice. J Traditional Med. 2007;24:137-139.
34. Miura T, Kurata M, Takagi S, Ishibashi C. Postprandial hyperglycemia, Fuscoporia. J Trad. Chin Med. 2008; 28:49-57.
35. Sun JE, Ao ZH, Lu ZM, Xu HY, Zhang XM, Dou WF, et al. Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxian-diabetes mice. J Ethnopharmacol. 2008;118:7-13.
36. Hosoe T, Iizuka T, Chiba Y, Itabashi T, Morita H. Eburicoic acid: relaxing effects of phellinus gilvus extract and purified eburicoic acid on rat aortic rings. J Natural Med. 2006;60:130-134.
37. Koyama T, Taka A, Togashi H. Cardiovascular effects produced by a traditionl fungal medicine, Fuscoporia obliqua extract, and microvessels in the left ventricular wall of stroke-prone spontaneously hypertensive rat (SHRSP). Clin Hemorheol Microcirc. 2006;35:491-498.
38. Yonei Y, Takahashi Y, Matsushita K, Watanabe M, Yoshioka T. Double blind study of health claims for food containing extract of kabanoanatake (Chaga, Fuscoporia obliqua) CRCT: randomized controlled study. Anti-aging Med. 2007;4:1-10.
39. Maenaka T, Oshima M, Itokawa Y. Effects of Fuscoporia obliqua on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients. J Tr Ch Med. 2008; 28:49-57.
40. Ryan TJ. Traditional health knowledge; integration of Western and Asian medicine. In: Niimi H, Xiu RJ, Sawada T, et al. editors, Microcirculatory Approach to Asian Traditional Medicine: Strategy for the Scientific Evaluation. Amsterdam:Elsevier. 1996; p. 11-16.
41. Koyama T. Expectations of traditional Chinese medicine. In: Niim H, Xiu RJ, Sawada T, et al. editors, Microcirculatory Approach to Asian Traditional Medicine: Strategy for the Scientific Evaluation. Amsterdam: Elsevier. 1996; p. 17-22.
42. Ryan TJ. Report from Asia: what is new in the field of microcirculation. J Alternat Complem Med. 2002;8: 91-92.